The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.

Curr Control Trials Cardiovasc Med · 2002 · PMC134475 · PMID 11985777

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

First and foremost, the possibility of a null treatment effect cannot be ignored given the wide confidence intervals (and hence marginally significant p value of 0.048) for the effect of atorvastatin on the primary efficacy endpoint.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.